Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
Q1 2026 earnings • released • EPS beat +13,15% • Revenue beat +2,77%
See results
MRK:NYSE
Merck & Co Inc
USD 112,16
+2,73%
(+2,98) 1D
USD 112,15
-0,01% (-0,0094)
After hours
Closed: 1 Mei, 16:00:34 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
USD 112,33
High
USD 114,54
Low
USD 111,88
Mkt. cap
277,02 mjd
Volume
11,95 m
Dividend
3,03%
Quarterly dividend
USD 0,85
Ex dividend date
16 Mrt. 2026
P/E ratio
31,56
52-wk high
USD 125,14
52-wk low
USD 73,31
EPS
USD 3,55
Beta
0,27
Shares outstanding
2,47 mjd
No. of employees
74 k
News stories
From sources across the web
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74 k
Founded01 Jan. 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Last report
30 Apr. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-1,28/ (-1,47 est.)USD
+13,15%beat
Revenue / Estimate
16,29 mjd/ (15,85 mjd est.)USD
+2,77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
15,53 mjd
15,81 mjd
17,28 mjd
16,40 mjd
Cost of goods sold
3,38 mjd
3,39 mjd
3,74 mjd
4,30 mjd
Cost of revenue
3,38 mjd
3,39 mjd
3,74 mjd
4,30 mjd
Research and development expenses
3,52 mjd
4,00 mjd
4,00 mjd
4,00 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,40 mjd
2,50 mjd
2,48 mjd
2,73 mjd
Operating expense
5,92 mjd
6,49 mjd
6,48 mjd
6,73 mjd
Total operating expenses
9,31 mjd
9,88 mjd
10,23 mjd
11,02 mjd
Operating income
6,22 mjd
5,92 mjd
7,05 mjd
5,38 mjd
Other non operating income
91,00 m
69,00 m
-
41,00 m
EBT including unusual items
5,90 mjd
5,00 mjd
6,74 mjd
3,42 mjd
EBT excluding unusual items
6,02 mjd
5,68 mjd
6,76 mjd
4,98 mjd
Income tax expense
818,00 m
571,00 m
958,00 m
458,00 m
Effective tax rate
13,86%
11,42%
14,20%
13,39%
Other operating expenses
-
-
-
-
Net income
5,08 mjd
4,43 mjd
5,78 mjd
2,96 mjd
Net profit margin
32,71%
28,01%
33,49%
18,07%
Earnings per share
2,22
2,13
2,58
2,04
Interest and investment income
109,00 m
69,00 m
96,00 m
69,00 m
Interest expense
-313,00 m
-305,00 m
-327,00 m
-411,00 m
Net interest expenses
-204,00 m
-236,00 m
-231,00 m
-342,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
7,28 mjd
6,99 mjd
8,15 mjd
6,79 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer